DocSym
β
Searchsearch
Search
(C46.3) Kaposi sarcoma of lymph nodes
More details coming soon
19 407 in individuals diagnosis kaposi sarcoma of lymph nodes confirmed
8 015 deaths with diagnosis kaposi sarcoma of lymph nodes
41% mortality rate associated with the disease kaposi sarcoma of lymph nodes
Diagnosis kaposi sarcoma of lymph nodes is diagnosed Men are 14.77% more likely than Women
11 137
Men receive the diagnosis kaposi sarcoma of lymph nodes
5 221 (46.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
8 270
Women receive the diagnosis kaposi sarcoma of lymph nodes
2 794 (33.8 %)Died from this diagnosis.
Risk Group for the Disease kaposi sarcoma of lymph nodes - Men and Women aged 80-84
In Men diagnosis is most often set at age 5-9, 15-19, 35-95+
Less common in men the disease occurs at Age 0-5, 10-14, 20-34Less common in women the disease occurs at Age 0-1, 25-34, 40-44, 90-94
In Women diagnosis is most often set at age 0-24, 35-39, 45-89, 95+
Disease Features kaposi sarcoma of lymph nodes
Absence or low individual and public risk
Kaposi sarcoma of lymph nodes - what does this mean
Kaposi sarcoma of lymph nodes is a type of cancer that occurs when the lymph nodes become infected with the human herpes virus 8. this virus can cause the cells in the lymph nodes to become abnormal and form tumors. these tumors can spread throughout the lymphatic system and other organs, and can be life-threatening if not treated.
What happens during the disease - kaposi sarcoma of lymph nodes
Kaposi sarcoma of lymph nodes is caused by a herpes virus known as the human herpes virus 8 (hhv-8). the virus is spread through contact with infected blood, saliva, or other bodily fluids. once the virus enters the body, it infects the lymph nodes and can cause the cells to become cancerous. this can lead to the growth of tumors in the lymph nodes, which can cause swelling, pain, and other symptoms.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the affected area
- Biopsy of the affected area
- Imaging tests such as X-ray, CT scan, MRI, or PET scan
- Blood tests including complete blood count (CBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels
- Lymph node biopsy
- Tissue culture
- Flow cytometry
- Immunohistochemistry
- Molecular testing
Treatment and Medical Assistance
Main goal: Reduce the size of the Kaposi sarcoma tumors and improve the patient's quality of life.
- Administering chemotherapy drugs to reduce the size of the tumors
- Prescribing antiviral medications to reduce the risk of infection
- Providing supportive care to manage symptoms and improve quality of life
- Performing radiotherapy to reduce tumor size
- Performing surgery to remove the tumors
- Administering immunotherapy to boost the immune system
- Providing psychological support to help the patient cope with the diagnosis and treatment
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Kaposi sarcoma of lymph nodes - Prevention
Kaposi sarcoma of lymph nodes can be prevented by avoiding exposure to the human herpesvirus 8 (hhv-8) which is the cause of the disease. it is important to practice safe sex, avoid sharing needles, and avoid contact with saliva, blood, or other body fluids of an infected person. vaccines are currently not available for this virus.